Announcing the Cardiovascular Innovations and Applications (CVIA) 2024 Impact Factor is 1.4

The Co-Editors-in-Chief of Cardiovascular Innovations and Applications (CVIA), Jamie B. Conti, University of Florida, Gainesville, FL, USA, Jianzeng Dong, Beijing Anzhen Hospital, Capital Medical University, Beijing, China and Jun Pu, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China, are pleased to announce that the 2024 Journal Impact Factor (JIF) for CVIA is 1.4.

Submissions to Cardiovascular Innovations and Applications (CVIA) can be made using ScholarOne, the online submission and peer review system. Registration and access are available at https://mc04.manuscriptcentral.com/cvia-journal. There are no author submission or article processing fees.

Articles of interest include:

Machine Learning Methods in Real-World Studies of Cardiovascular Disease

The Evolving Role of Transcatheter Tricuspid Valve Edge-to-Edge Repair in Tricuspid Regurgitation

Overview of Postural Orthostatic Tachycardia Syndrome (POTS) for General Cardiologists

Experience in Application of a Three-Dimensional Pulsed Field Ablation System Integrating Mapping and Ablation

Angiography-Based Computational Modeling for In Vivo Assessment of Endothelial Dynamic Strain in Coronary Arteries with De Novo Lesions: Comparison of Treatment Effects of Drug-Coated Balloons Between Small and Large Arteries

Feasibility of an Integrated Digital and Pharmacological Approach Targeting Blood Lipids in Atherosclerotic Cardiovascular Disease Management

Association between Percentage of Neutrophils at Admission and in-Hospital Events in Patients ≥75 Years of Age with Acute Coronary Syndrome

Heart Failure Guideline Directed Medical Therapy: Which One and When?

Overview of Injectable Hydrogels for the Treatment of Myocardial Infarction

Surgical Treatment of Aortic Annulus Damaged by Infective Endocarditis: A Single-Center Experience